Medtronic has recalled certain MiniMed insulin pumps due to cybersecurity risks, and will provide alternative pumps to the estimated 4,000 U.S. patients using the pumps, the Food and Drug Administration announced yesterday. The small computerized pumps deliver insulin to a patient throughout the day through a catheter implanted under the skin, and wirelessly connect to a meter and monitoring system that measure and track the patient’s blood glucose levels. FDA said someone other than a patient or care provider could connect wirelessly to the pump and change its settings or stop insulin delivery, leading to high or low blood sugar or a buildup of acids in the blood. The agency recommends health care providers review with patients who have a recalled device the recommended safety precautions while waiting for a replacement device. FDA also urges device manufacturers to monitor and assess cybersecurity vulnerability risk and “be proactive about disclosing vulnerabilities and mitigations to address them,” said Suzanne Schwartz, M.D., deputy director of the Office of Strategic Partnerships and Technology Innovation at FDA’s Center for Devices and Radiological Health.

Related News Articles

Headline
The Health and Public Health Sector Coordinating Council, a public-private partnership, yesterday released a crisis response guide to help health care…
Headline
The Healthcare and Public Health Sector Coordinating Council, a public-private partnership developed to mitigate threats to the nation’s health care sector,…
Headline
China and its proxies have been observed attempting to identify and illicitly obtain valuable intellectual property and public health data related to vaccines…
Headline
The Department of Homeland Security and the Cybersecurity and Infrastructure Security Agency have updated their telework guidance to include new guidance on…
Headline
Cyber actors have launched phishing campaigns against first responders, initiated denial-of-service assaults against government agencies and threatened medical…
Headline
The FBI warned today of specific COVID-19-themed email phishing campaigns targeting U.S.-based medical providers. The campaigns leverage email subject lines…